Team:HKU HongKong/Project/Background.html
From 2012.igem.org
(Difference between revisions)
Line 482: | Line 482: | ||
</ul> | </ul> | ||
<p> </p> | <p> </p> | ||
- | <h2 style="font-variant: normal; vertical-align: baseline; clear: left; color: #232323; font-family: Gentium Basic; letter-spacing: normal; line-height: 19.5px; orphans: 2; text-align: | + | <h2 style="font-variant: normal; vertical-align: baseline; clear: left; color: #232323; font-family: Gentium Basic; letter-spacing: normal; line-height: 19.5px; orphans: 2; text-align: justify; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px; border: 0px none; margin: 0.7em 0px; padding: 0px"> |
- | + | <span style="font-weight: 400; text-decoration: underline"> | |
- | + | <font face="Trebuchet MS" size="6">Bio-bricks:</font></span></h2> | |
- | + | <p style="text-align: justify; font-style: normal; font-variant: normal; font-weight: normal; font-size: 13px; vertical-align: baseline; color: rgb(85, 85, 85); font-family: Lato, Tahoma, Arial, sans-serif; letter-spacing: normal; line-height: 19.5px; orphans: 2; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px; border: 0px none; margin-left: 0px; margin-right: 0px; margin-top: 0px; margin-bottom: 20px; padding: 0px"> | |
- | + | </p> | |
- | + | <h2 style="margin:0.7em 0px; text-align: justify; font-variant: normal; vertical-align: baseline; color: #232323; font-family: Gentium Basic; letter-spacing: normal; line-height: 19.5px; orphans: 2; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px; border: 0px none; padding: 0px; clear:left"> | |
- | + | <span style="color: rgb(35, 35, 35); font-family: Lato, Tahoma, Arial, sans-serif; font-size: 13px; font-style: normal; font-variant: normal; letter-spacing: normal; line-height: 19.5px; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px; display: inline !important; float: none; background-color: rgb(255, 255, 255)"> | |
- | + | 1)</span><span style="color: rgb(35, 35, 35); font-family: Lato, Tahoma, Arial, sans-serif; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: 19.5px; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); display: inline !important; float: none; "> | |
- | + | </span><font face="Tahoma" size="2"><b>Constitutive Promoter (J23119) + Ribosomal | |
- | + | Binding Site (B0034) + pvdQ Gene + Double Terminator (B0015)</b></font></h2> | |
- | + | <p style="margin:0.7em 0px; text-align: justify; font-variant: normal; vertical-align: baseline; color: #232323; font-family: Gentium Basic; letter-spacing: normal; line-height: 19.5px; orphans: 2; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px; border: 0px none; padding: 0px; clear:left"> | |
- | + | <img border="0" src="https://static.igem.org/mediawiki/2012/2/27/1_biobrick.jpg" width="676" height="157"></p> | |
- | + | <p style="margin:0.7em 0px; text-align: justify; font-variant: normal; vertical-align: baseline; color: #232323; font-family: Gentium Basic; letter-spacing: normal; line-height: 19.5px; orphans: 2; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px; border: 0px none; padding: 0px; clear:left"> | |
- | + | </p> | |
- | + | <p style="text-align: justify; font-style: normal; font-variant: normal; font-weight: normal; font-size: 13px; vertical-align: baseline; color: #232323; font-family: Lato, Tahoma, Arial, sans-serif; letter-spacing: normal; line-height: 19.5px; orphans: 2; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px; border: 0px none; margin-left: 0px; margin-right: 0px; margin-top: 0px; margin-bottom: 20px; padding: 0px"> | |
- | + | This biobrick was constructed to test the | |
- | + | expression of the pvdQ gene amplified by PCR from genomic DNA of Pseudomonas | |
- | + | aeruginosa. It is an uncontrollable, standard biobrick that can later be used as | |
- | + | a baseline reference to test whether our future biobricks result in an | |
- | + | improvement in pvdQ expression level. The biobrick is a composite part | |
- | + | consisting of the already prevalent Constitutive Promoter [2006 Berkley], along | |
- | + | with the newly inserted pvdQ gene. It is also composed of a strong RBS and a | |
- | + | transcription double terminator. </font> | |
- | + | <p style="text-align: justify; font-style: normal; font-variant: normal; font-weight: normal; font-size: 13px; vertical-align: baseline; color: #232323; font-family: Lato, Tahoma, Arial, sans-serif; letter-spacing: normal; line-height: 19.5px; orphans: 2; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px; border: 0px none; margin-left: 0px; margin-right: 0px; margin-top: 0px; margin-bottom: 20px; padding: 0px"> | |
- | + | <b>Constitutive Promoter (J23119):</b> | |
- | + | This promoter biobrick is the consensus sequence and therefore results in the | |
- | + | idealized transcription scenario. Since it is a strong promoter and is | |
- | + | constitutively expressed, it complies with our preliminary goal of testing | |
- | + | transcription and translation of the pvdQ gene in an AHL-independent manner<br> | |
- | + | <br> | |
- | + | <br> | |
- | + | </span><span style="font-size: 10pt; font-family: Tahoma">2) </span></font> | |
- | + | <font color="#232323" size="2" face="Tahoma"><b>LacI Promoter, RBS, LuxR Gene, | |
- | + | Double Terminator, LuxR Promoter, & RBS (K137076) + pvdQ Gene + Double | |
- | + | Terminator (B0015) </b> </font> | |
- | + | <h2 style="text-align: justify"></h2> | |
- | + | <p style="text-align: justify"> | |
- | + | <img border="0" src="https://static.igem.org/mediawiki/2012/0/0a/2_biobrick.jpg" width="935" height="182"></p> | |
- | + | <p style="text-align: justify; font-style: normal; font-variant: normal; font-weight: normal; font-size: 13px; vertical-align: baseline; color: #232323; font-family: Lato, Tahoma, Arial, sans-serif; letter-spacing: normal; line-height: 19.5px; orphans: 2; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px; border: 0px none; margin-left: 0px; margin-right: 0px; margin-top: 0px; margin-bottom: 20px; padding: 0px"> | |
- | + | This biobrick was constructed to test the expression of the pvdQ gene in an environment containing the 3OC<sub>12</sub>-HSL | |
- | + | substrate. However, the synthesis of pvdQ is not exclusively dependent on AHL. | |
- | + | This is because the LacI+pI promoter that initiates transcription of the LuxR | |
- | + | gene can be effectively induced by IPTG. Moreover, the LuxR promoter is also | |
- | + | expressed well in the absence of LuxR and AHL. The biobrick is composed part of | |
- | + | the already existing K137076 [2008 Caltech] as well as the pvdQ gene and double | |
- | + | terminator sequence. The first 1,096bp of the K237076 biobrick containing the | |
- | + | LacI and LuxR promoters, two RBS, and the LuxR gene was amplified using the | |
- | + | standard Prefix primer and a newly designed Suffix primer. </p> | |
- | + | <p style="text-align: justify; font-style: normal; font-variant: normal; font-weight: normal; font-size: 13px; vertical-align: baseline; color: #232323; font-family: Lato, Tahoma, Arial, sans-serif; letter-spacing: normal; line-height: 19.5px; orphans: 2; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px; border: 0px none; margin-left: 0px; margin-right: 0px; margin-top: 0px; margin-bottom: 20px; padding: 0px"> | |
- | + | We chose the biobrick K137076 to | |
- | + | ligate to the pvdQ gene for the following reasons: </font></p> | |
- | + | <ul> | |
- | + | <li> | |
- | + | <p style="text-align: justify"> | |
- | + | <font size="2" face="Tahoma" color="#232323"> K137076 | |
- | + | consists of a strong, continually expressed promoter (R0011) that can, | |
- | + | however, be further induced by IPTG. Such a promoter allows us to control | |
- | + | the expression of the LuxR protein. <br> | |
- | + | </font></li> | |
- | + | <li> | |
- | + | <p style="text-align: justify"> | |
- | + | <font size="2" face="Tahoma" color="#232323">The complex formed when two | |
- | + | molecules of LuxR bind to two molecules of AHL, attaches to a palindromic | |
- | + | site on the pLuxR to transcribe the pvdQ gene.This pLuxR promoter however | |
- | + | causes leaky expression of pvdQ as it can be induced even in the absence of | |
- | + | LuxR and AHL. <br> | |
- | + | </font></li> | |
- | + | </ul> | |
- | + | <p class="MsoNormal" style="text-align: justify"> | |
- | + | <font size="2" face="Tahoma" color="#232323"> </font><font color="#232323"><span style="font-size: 10pt; font-family: Tahoma"><br> | |
- | + | </span><b><font size="2" face="Tahoma">3). Constitutive </font></b> | |
- | + | <span style="font-size: 10pt; font-family: Tahoma">Promoter</span><b><font size="2" face="Tahoma"> | |
- | + | (pLacI) + Ribosomal Binding Site + LuxR Gene + Double Terminator + LuxR Promoter | |
- | + | (J09855) + Ribosomal Binding Site (B0034) + pvdQ Gene + Double Terminator | |
- | + | (B0015)</font></b></font></p> | |
- | + | <p class="MsoNormal" style="text-align: justify"> | |
- | + | <img border="0" src="https://static.igem.org/mediawiki/2012/6/6d/3_biobrick.jpg" width="945" height="184"></p> | |
- | + | <p style="text-align:justify;text-justify:inter-ideograph"> | |
- | + | <font size="2" face="Tahoma" color="#232323">This biobrick was constructed such | |
+ | that</font></p> | ||
+ | <p class="MsoNormal" style="text-align:justify;text-justify:inter-ideograph"> | ||
+ | <br> | ||
+ | </p> | ||
+ | <p class="MsoNormal" style="text-align: left"><b> | ||
+ | <font size="2" face="Tahoma" color="#232323">4). </font> | ||
+ | <font size="2" face="Tahoma" color="#232323">LuxR Promoter (R1062) + Ribosomal | ||
+ | Binding Site, LuxR Gene, Double Terminator, & Ribosomal Binding Site (amplified | ||
+ | from K137076) + pvdQ Gene + Double Terminator (B0015)</font></b></p> | ||
+ | <p class="MsoNormal" style="text-align: left"> | ||
+ | <img border="0" src="https://static.igem.org/mediawiki/2012/8/87/4_biobricks.jpg" width="864" height="173"></p> | ||
+ | <p style="text-align: justify; text-justify: inter-ideograph"> | ||
+ | <font face="Tahoma" size="2" color="#232323"><br> | ||
+ | This final biobrick is entirely an AHL-dependent system, as an identical | ||
+ | promoter controls the transcription and translation of both the LuxR and the | ||
+ | pvdQ gene. This LuxR promoter, unlike its Bba_R0062 counterpart, is only weakly | ||
+ | expressed in the absence of LuxR and AHL. However, a desirable positive feedback | ||
+ | mechanism is generated upon coupling of AHL with the LuxR protein. The AHL-LuxR | ||
+ | complex binds to p<sub>LuxR</sub> and upregulates gene expression. As more LuxR | ||
+ | is expressed, subsequent pairing of the molecules further activates the | ||
+ | promoter. Thereby, a large yield of pvdQ is obtainable at low cell density. The | ||
+ | outcome is advantageous as biofilm formation can be interrupted at an early | ||
+ | stage. </font></p> | ||
+ | <p style="text-align:justify;text-justify:inter-ideograph"> | ||
+ | <font size="2" face="Tahoma" color="#232323"> </font></p> | ||
+ | <p class="MsoNormal"> </p> | ||
+ | <p style="text-align: justify"> </p> | ||
+ | <h2 style="margin:0.7em 0px; text-align: justify; font-variant: normal; vertical-align: baseline; color: #232323; font-family: Gentium Basic; letter-spacing: normal; line-height: 19.5px; orphans: 2; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px; border: 0px none; padding: 0px; clear:left"> | ||
+ | </h2> | ||
+ | <h2 style="margin:0.7em 0px; text-align: justify; font-variant: normal; vertical-align: baseline; color: #232323; font-family: Gentium Basic; letter-spacing: normal; line-height: 19.5px; orphans: 2; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px; border: 0px none; padding: 0px; clear:left"> | ||
+ | </h2> | ||
</body> | </body> | ||
- | |||
</html> | </html> |
Revision as of 08:08, 23 September 2012